How a Targeted Valve Recall and Watchman Questions at Boston Scientific (BSX) Have Changed Its Investment Story

Earlier in June 2026, the US Food and Drug Administration posted a Class II, firm-initiated recall of 9,750 Boston Scientific ...
MassDevice

Analysts ‘remain constructive’ on Boston Scientific opportunity ahead with PFA, Watchman

BTIG analysts remain high on Boston Scientific (NYSE:BSX) following meetings with the company's management this week.

Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition

Boston Scientific (BSX) stock has been under pressure after management flagged slowing growth in its Watchman heart implant business, a key contributor to earnings. The company reaffirmed full year ...
TCTMD

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

DENVER, CO—Final 5-year data from the PROTECT AF and PREVAIL trials of the Watchman left atrial appendage (LAA) closure device (Boston Scientific) continued to show similar overall stroke prevention ...